Genzyme Launches New Cystic Fibrosis Gene Sequencing Test

... Genzyme Corporation (Nasdaq: GENZ) announced today the commercial availability of cystic fibrosis (CF) gene sequencing, a new diagnostic test that can detect approximately 98 percent of the more than 1,200 disease-causing mutations in the CFTR gene. Mutations in the CFTR gene can cause CF, as well as other health issues such as pancreatitis and male infertility. [click link for full article] ...